Baixar Oncology Nursing Drug Handbook - v3.5.13

Existem alguns APLICATIVOS tão bons quanto X-RAY WOW, NYP, Inject App, Patchwork, ALAT, Medical PG, FMGE Preparation - PrepLadder, e Oncology Nursing Drug Handbook - v3.5.13 também, um dos melhores APLICATIVOS do gênero Medicina.

Desenvolvido por Skyscape Medpresso Inc, Oncology Nursing Drug Handbook - v3.5.13 requer versão Android de pelo menos Android 5.0+. Portanto, você deve atualizar seu telefone se necessário.

Oncology Nursing Drug Handbook - v3.5.13 APK a versão mais recente é 3.5.13, data de lançamento 2020-06-25 e tem tamanho 8.4 MB.

Estatísticas sobre 1000 downloads estão disponíveis no Google Play. Você pode atualizar aplicativos que foram baixados ou instalados individualmente em seu dispositivo Android, se desejar. Atualizar seus aplicativos oferece mais.acesso aos recursos mais recentes e aumenta a segurança e estabilidade da aplicação.

Porque nem todos os jogos ou aplicativos são compatíveis com todos os telefones. E o jogo ou aplicativo não está disponível para o seu dispositivo, depende da versão do sistema operacional Android, resoluções de tela ou países aos quais o Google Play permite acesso. Então, no APK4Share você pode baixar arquivos APK facilmente e não estar sujeito a essas restrições.

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity